Pancreatic Cancer Research

ResearcherHouston MethodistActive in the last 2 years

Min Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1310-2503; OpenAlex author ID A5106387597. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
64
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 4 papers

Papers 13

  1. Exploring the clinical significance of TPX2 in pancreatic cancer: from biomarker to immunotherapy. Co-author DOI 10.1007/s00210-024-03628-0↗
  2. Improved survival in pancreatic ductal adenocarcinoma: Exciting promise of multimodal management strategies. First author DOI 10.1016/j.canlet.2025.217828↗
  3. CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy. First author DOI 10.1016/j.canlet.2025.217905↗
  4. Hypoxia-augmented chemotherapy potentiates imaging-guided combinatorial radionuclide-sonodynamic therapy for pancreatic cancer. Co-author DOI 10.1186/s12951-025-03611-8↗
  5. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges. Co-author DOI 10.1007/s11684-023-1050-6↗
  6. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis. Co-author DOI 10.1016/j.canlet.2020.02.039↗
  7. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Co-author DOI 10.1186/s12943-020-01249-8↗
  8. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1158/1078-0432.ccr-18-4113↗
  9. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism. Last author DOI 10.1158/1078-0432.ccr-18-0263↗
  10. Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/m… Co-author DOI 10.1038/srep19222↗
  11. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Co-author DOI 10.18632/oncotarget.6819↗
  12. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Co-author DOI 10.1186/s12943-015-0315-3↗
  13. Circulating tumor cells in the diagnosis and management of pancreatic cancer. Last author DOI 10.1016/j.bbcan.2012.05.007↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marco Cordani · 1 shared paper, 2025 · strength 0.54
  2. Murray Korc · 1 shared paper, 2025 · strength 0.54
  3. Cunsi Shen · 1 shared paper, 2025 · strength 0.30
  4. Zhengguang Zhang · 1 shared paper, 2025 · strength 0.30
  5. Fuqiong Zhou · 1 shared paper, 2025 · strength 0.30
  6. Xiaohao Zheng · 1 shared paper, 2023 · strength 0.26
  7. Zhichen Jiang · 1 shared paper, 2023 · strength 0.26
  8. Mingyang Liu · 1 shared paper, 2023 · strength 0.26
  9. Jingxuan Yang · 4 shared papers, 2012–2019 · strength 0.22
  10. Jie An · 1 shared paper, 2025 · strength 0.21
  11. Sijin Li · 1 shared paper, 2025 · strength 0.21
  12. Lianxin Liu · 2 shared papers, 2019–2020 · strength 0.15
  13. Mingyang Liu · 2 shared papers, 2018–2019 · strength 0.12
  14. Courtney W. Houchen · 2 shared papers, 2016–2018 · strength 0.11
  15. Wen-Quan Wang · 2 shared papers, 2016 · strength 0.10
  16. Jin-Feng Xiang · 2 shared papers, 2016 · strength 0.10
  17. Jin Xu · 2 shared papers, 2016 · strength 0.10
  18. Huaxiang Xu · 2 shared papers, 2016 · strength 0.10
  19. Liang Liu · 2 shared papers, 2016 · strength 0.10
  20. Jiang Long · 2 shared papers, 2016 · strength 0.10
  21. Chuntao Wu · 2 shared papers, 2016 · strength 0.10
  22. Xianjun Yu · 2 shared papers, 2016 · strength 0.10
  23. Chen Liu · 2 shared papers, 2016 · strength 0.10
  24. Qiushi Lin · 1 shared paper, 2020 · strength 0.08
  25. Bei Sun · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.